Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
6.8%, p = 0.0066)
Novo Nordisks Peter Johannsen, MD, highlighted the biological signals observed and acknowledged the clinical limitations: subgroup analyses did not reveal meaningful benefit, and any potential responder group would be very small
Diab Metab Syndr
STAR Protoc
Accordingly, the greater observed reduction in HOMA-IR with liraglutide likely reflects baseline differences rather than intrinsic superiority of the agent
US$ 26.82
US$ 21.08
US$ 28.72
US$ 20.60
US$ 22.53
US$ 24.30
US$ 23.10
US$ 23.48
US$ 24.33
